Neogenomics (NEO) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to -$87.8 million.
- Neogenomics' Other Gross PP&E Adjustments rose 224.93% to -$87.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$87.8 million, marking a year-over-year increase of 224.93%. This contributed to the annual value of $200.6 million for FY2024, which is 2876.05% up from last year.
- According to the latest figures from Q3 2025, Neogenomics' Other Gross PP&E Adjustments is -$87.8 million, which was up 224.93% from -$98.1 million recorded in Q2 2025.
- Neogenomics' Other Gross PP&E Adjustments' 5-year high stood at $200.6 million during Q4 2024, with a 5-year trough of -$127.3 million in Q1 2022.
- In the last 5 years, Neogenomics' Other Gross PP&E Adjustments had a median value of -$98.1 million in 2025 and averaged -$47.4 million.
- In the last 5 years, Neogenomics' Other Gross PP&E Adjustments plummeted by 12921.74% in 2021 and then surged by 2876.05% in 2024.
- Quarter analysis of 5 years shows Neogenomics' Other Gross PP&E Adjustments stood at $114.9 million in 2021, then increased by 17.98% to $135.5 million in 2022, then increased by 14.99% to $155.8 million in 2023, then increased by 28.76% to $200.6 million in 2024, then plummeted by 143.75% to -$87.8 million in 2025.
- Its last three reported values are -$87.8 million in Q3 2025, -$98.1 million for Q2 2025, and -$102.8 million during Q1 2025.